pre-IPO PHARMA

COMPANY OVERVIEW

Zikani Therapeutics is using its innovative chemistry technology platform to develop novel Ribosome Modulating Agents (RMAs). We are focused on developing and commercializing therapeutics for patients with limited treatment options.


LOCATION

  • Watertown, MA, USA

  • THERAPEUTIC AREAS

  • Infectious Disease

  • WEBSITE

    https://www.macrolide.com


    CAREER WEBSITE

    https://www.macrolide.com/careers/


    SOCIAL MEDIA


    INVESTORS

    advent-life-sciences gurnet-point-capital m-ventures novartis-venture-fund roche-venture-fund sr-one


    PRESS RELEASES


    Apr 1, 2021

    Eloxx Pharmaceuticals Acquires Zikani Therapeutics


    Jul 16, 2020

    Zikani Therapeutics Appoints Chief Scientific and Medical Officer


    Apr 20, 2020

    Zikani Therapeutics Completes Series A-1 Funding


    For More Press Releases


    Google Analytics Alternative